In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Karo Pharma AB

http://karopharma.se/

Latest From Karo Pharma AB

European OTC Results Round-Up: Boiron, Alliance Pharma and Karo

COVID-19 had a differing impact on Q2 consumer health sales for France's Boiron, the UK's Alliance Pharma and Sweden's Karo.

Sales & Earnings OTC Drugs

UK Marketing: Sanofi Launches Buscomint, New Releases From Salonpas and Nailner

The latest OTC launches in the UK, including Buscomint from Sanofi, Salonpas Gel-Patch from Hisamitsu and Nailner Active Cover from Karo.

Innovation Launches

Deal Watch: Roche And Vividion Will Investigate E3 Ligases In Cancer, Immunology

Also, news on transactions involving Neurocrine/Idorsia, Neurotrope/Metuchen, jCyte/Santen, PTC/Censa, Hoth/Chelexa, Skyhawk/Merck & Co., Orexo/Gaia, Karo/J&J, MaxCyte/Caribou, Mediolanum/ElsaLys, Avectas/ONK

Deals Business Strategies

Karo Pharma Grabs J&J’s Pevaryl Brand In Europe

Karo has picked up the full European rights to the Pevaryl antifungal brand from Johnson & Johnson.

Europe Deals
See All

Company Information

  • Industry
  • Services
  • Pharmaceuticals
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • MedCore AB
    • Karo Pharma AB
    • BioPhausia
UsernamePublicRestriction

Register